A comparative debate on the various anti-vascular endothelial growth factor drugs: pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin). (Q36977435)
Jump to navigation
Jump to search
scientific article published on November 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A comparative debate on the various anti-vascular endothelial growth factor drugs: pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin). |
scientific article published on November 2007 |
Statements
1 reference
A comparative debate on the various anti-vascular endothelial growth factor drugs: pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin). (English)
1 reference
Manish Nagpal
1 reference
Kamal Nagpal
1 reference
P N Nagpal
1 reference
1 November 2007
1 reference
10 references
25 April 2019
17 September 2019
27 September 2019
20 November 2019
27 November 2019
13 December 2019
20 August 2020
14 October 2020
5 November 2020
437-439
1 reference
9 references
25 April 2019
17 September 2019
27 September 2019
20 November 2019
27 November 2019
13 December 2019
20 August 2020
14 October 2020
5 November 2020
Identifiers
1 reference
1 reference
1 reference